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Abstract 
Many solutions have been proven to effectively and safely control drug dosage in several medical 
problems. They encounter however barriers in practical application due to the following characteristics: 
medical models are very challenging to acquire, the need for deep control knowledge by the user, lack of safe 
measurement and actuation devices, and finally, the abstraction from real world problems. We developed a 
model that aims to reduce the impact of these difficulties in the deployment of real world automatic 
administration systems. Our system is based on multi model architecture that allows for adaptative rule 
creation and algorithm effectiveness evaluation, focused on the automatic control of hypertension in the 
intensive care unit.  
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1. Introduction  
 
Control systems research has a long history of mathematical rigor, with applications on diverse branches of 
science. Successful applications are used in many fields of knowledge, however, medical control systems 
have special characteristics: they are less mature, have wide impact on human life and are less established [1 , 
2]. 
With the increase of computer capabilities and the development of control methodologies, automatic drug 
administration is today a widespread concept. Many solutions have been proven to effectively and safely 
control drug dosage in several medical problems like anesthesiology, blood pressure control and insulin 
administration. The interested reader is referred to [3] for a thorough review of soft computing techniques and 
systems used for automatic drug administration.  
Despite the number of quality research available, there is still the need to attain the seamless integration of 
these systems. Several studies conducted in the control community revealed that real world implementations 
of automatic administration systems encountered resistances related in part to the following characteristics: 
medical models are very challenging to acquire, the need for a deep understanding of control theory by the 
end user of the existing solutions, lack of appropriate and safe measurement and actuation devices, and 
finally, the excessive abstraction from real world problems [3, 4].  
In this paper we develop a model that aims to reduce the impact of the above mentioned characteristics in 
deployment of real world automatic administration systems. The resulting multi model architecture was 
specifically designed for the automatic control of hypertension in the intensive care unit (ICU). However it is 
worthwhile to stress that despite the specificity of the developed solution, it is possible to extrapolate the core 
concepts of the methodology to other drugs and medical problems. 
2. Background on physiological control variables of hypertension in ICU 
In this work we intend to provide the founding grounds for the synthesis of safety-critical controllers from 
data driven generated models for real world applications. 
In the absence of a rigorous patient model needed to accurately predict the response before the 
administration, a large amount of knowledge associated with the healthcare professionals, that manually do 
the administrations, is already available. We proceeded to gather the medical information available, 
understanding the human body functions, in order to create rules that could restrict the administration for 
safety reasons. A brief medical explanation behind the rules that are present in this document was delivered as 
an appendix. However, due to the maximum number of pages allowed for publication, the reader may find the 
information in [5,6,7] . 
3. A systemic multi model methodology 
Automatic drug administration solutions are closed loop control systems that encapsulate a software 
algorithm, an user interface and hardware. 
These systems aim to provide intravenous administration of drugs in a controlled healthcare environment. 
This administration follows strict protocols that are bound to the healthcare facility, healthcare professional 
and patient characteristics. These protocols, despite strict are also very generic and do not provide enough 
knowledge about the patient control process. The patient model is closely related to the capabilities of the 
control system [3]. 
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The patient model is a mathematical abstraction of the patient’s biological characteristics. Ideally, it would 
be possible to map the patient’s information into a system of mathematical functions that would closely 
resemble the real person’s biological systems (respiratory and cardiac systems, for instance).   
Some of today’s most complete patient models and advanced studies about the patient response are applied 
to medical simulators, sold commercially by companies like Metti and Laerdal. 
However, due to the scarcity of information about some biological processes and significant variability 
between patients these models lack the precision to accurately represent biological systems. It is actually very 
challenging to develop an accurate patient model. 
3.1. Model Generation 
Most of the traditional controllers built to solve the hypertension problem are based on a mathematical 
model developed initially by Guyton [8]. However the linearity of the model prevents the accurate 
representation of nonlinear and time-varying features of the cardiovascular dynamics of the human body. Due 
to this characteristic, controller designs based purely on the model may not perform satisfactorily in practice. 
Modeling is in general a difficult task, however the accurate representation of biological processes 
involving nonlinearity, time variance, and time-delay is even more difficult due to the lack of information on 
the real time dynamics of the system. Patient characteristics vary immensely from person to person (inter 
patient variability). The same patient can also significantly change the biological response with multiple 
factors, such as time of the day or diet (intra patient variability). 
Such problems are common in design of model-based controllers and it is possible, through model free, 
data driven, control systems, to increase the accuracy of the process models [9]. Therefore it is necessary that 
the controller has the ability to modify its behavior (adapt its parameters) in response to changes in the 
dynamics of the process and environment disturbances. 
A broad spectrum of mathematical and analytical methods can be applied in the development of models for 
drug administration and dosage regulation. These models may be used to predict the drug dynamics and to 
generate conceptual insights about the procedure. 
 The methods available range from highly abstracted to highly specified as is illustrated in Fig. 1. 
 
 
Fig. 1. Model development tools [4] 
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The reader should keep in mind that Fig.1 does not illustrate all of the computational mining and modeling 
methodologies. The amount of knowledge that exists about the key components of the drug administration 
procedure determines the range of methodologies that can be used. 
While highly abstracted methods are most powerful when little prior knowledge exists, highly specified 
methods are most powerful when a deep and comprehensive amount of knowledge is available concerning not 
only the components, but also their connectivity and the mechanisms of their associated interactions. 
In between these two extremes are methods that enable determination of logical influences characterizing 
network component interactions.  
These methods include Bayesian network, Markov chain, decision tree, Boolean logic, and fuzzy logic 
models. At the more detailed end of the modeling spectrum is the development of numerical methods and 
software for ordinary differential equation solution, differential-algebraic equation solution, and sensitivity 
analysis of these types of systems.  
3.2. Multi model rule generation 
Early advances in the field of modeling and analysis for systems biology have guided supervised 
therapeutic interventions. However, to achieve safety requirements, it is necessary to constrain the data driven 
model generation tools. This is due to the amount of variables with high variability that need to be taken into 
account. Control may not be effective in the presence of too many unknown parameters. 
We realized that real world implementation of an automatic drug administration system would need to 
accommodate a large amount of patient characteristics, including biological variability and even other 
pathologies. This is different from the majority of the papers available that avoid the complexities of the 
patient model by developing very specific solutions, like the administration of Sodium Nitroprusside (SNP) to 
control hypertension after a surgery in otherwise pathology free patients. We understood exactly what the 
study [4]  meant when referring the abstraction from real world problems when we tried to select real patients 
to be incorporated in our investigation. The challenge was to select patients whose data (stored in the 
hospital's database) could be used to test published paper’s algorithms. The answer came out to be zero. From 
the 72 patients that received SNP treatment since 2005, no one could take advantage of an existing automatic 
drug administration system. While other systems effectively control the arterial pressure with SNP, they do 
not monitor other variables that are crucial for safe drug administration. As an example, the mean arterial 
pressure can be above the desired value, however, by lowering the arterial pressure the heart rate could go up. 
If the heart rate is already at a very high value, a healthcare professional can make the decision of altering the 
desired arterial pressure value, balancing the two variables. While this can be done manually, it makes no 
sense to try to develop an automatic system for drug administration that relieves medical professionals from 
constant attention but requires the constant attention of a control tuning professional. 
We developed four different models that can be used together and describe a portion of the medical 
knowledge that the health care professionals possess. From the analysis of the literature review, we identified 
4 cases in which the administration of SNP varies greatly. The difference between the models implies 
different safety rules. Additionally we found that these rules may be used to detect anomalies with the 
administration, unknown processes occurring and automatically evaluate the performance of the algorithm in 
real time. 
The 4 models are the “standard profile”, “hypertension profile”, “heart failure profile” and the “mitral 
regurgitation profile”. The standard profile encompasses major rules that are common to any SNP 
administration. It is used alone or in conjunction with the other models. The remaining 3 models are used 
taking into consideration the patient’s actual pathology, and the names are self-explanatory. 
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The selection of the model is important because it tells the system what rules should be placed for that 
treatment and what variables should be monitored and used for the patient model generation. The model 
selection and the variable thresholding (assigning the maximum, minimum and desired value for each 
variable) are the responsibility of the healthcare professional. They are configured in the beginning of the 
treatment and can be changed in real time. This is an added security feature that can be used to measure the 
system’s performance.  
We provide a brief insight about the medical information that constitutes each model. The tables bellow 
describe the variables that the system should monitor. These are the direct result of the medical study. 
However, not all of them can presently be integrated in the system for reasons we shall explain later in this 
paper. The expected parameter variation shown in table 1 is the average patient response to a dosage of 
3μg/kg/min. The starting dosage that is used to test general patient response is 0,5μg/kg/min. 
 
Table 1. Normal values and expectable variation after SNP administration in “Standard Profile” 
 
Standard profile 
Parameter  Normal range Expectable 
variation 
Mean arterial pressure 70-105 mmHg - 25 % 
Heart rate 60-100 bpm + 14.7 % 
Respiratory rate 
Capillary oxygen saturation 
Body temperature 
Urinary output 
pH 
PaO2 
PaCO2 
Glucose 
Lactates 
Thiocyanate 
Methemoglobin 
Creatinine 
Urinary sodium 
12-20 bpm 
92-100 % 
36-37.5 ºC 
1mL/kg/min 
7.35-7.45 
85-100 mmHg 
35-45 mmHg 
70-110 mg/dL 
0.3-2.3 mEq/L 
0.5-4.7 mg/dL 
0-3 % 
0.6-1.5 mg/dL 
10-40 mEq/L 
- 18 % 
+ 1 % 
+ 2.7 % 
- 15 % 
- 0.3 % 
- 2.1 % 
- 7.5 % 
+ 6 % 
- 32 % 
+ 34 % 
+ 0.6 % 
+ 44 % 
- 20 % 
 
Table 2. Normal values and expectable variation after SNP administration in “Hypertension Profile” 
 
Hypertension profile 
Parameter  Normal range Expectable 
variation 
Cardiac output 4-8 L/min + 31 % 
Systemic vascular resistances 900-1600 dyn.s/cm5 - 53 % 
Pulmonary vascular resistances 155-249  dyn.s/cm5 - 29.3 % 
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Table 3. Normal values and expectable variation after SNP administration in “Heart failure Profile” 
 
Heart failure profile 
Parameter  Normal range Expectable 
variation 
Cardiac index 2.5-4.2 L/min/m2 + 21 % 
Stroke volume 60-100 mL + 9 % 
Systemic vascular resistances 
Pulmonary vascular resistances 
Capillary wedge pulmonary pressure 
Central venous pressure 
Atrial natriuretic peptide 
Creatine kinase-isoenzyme MB 
900-1600 dyn.s/cm5 
155-249 dyn.s/cm5 
4-12 mmHg 
2-6 mmHg 
44-1500 pmol/L 
0-4 ng/mL 
- 32 % 
- 30.7 % 
- 80 % 
- 14.9 % 
- 70.5 % 
- 18.4 % 
 
Table 4. Normal values and expectable variation after SNP administration in “Mitral regurgitation Profile” 
 
Mitral regurgitation profile 
Parameter  Normal range Expectable 
variation 
Cardiac index 2.5-4.2 L/min/m2 + 36 % 
Stroke volume 60-100 mL + 9 % 
Systemic vascular resistances 
Pulmonary vascular resistances 
Mitral regurgitant volume 
Mitral regurgitant orifice area  
Creatine kinase-isoenzyme MB 
900-1600 dyn.s/cm5 
155-249 dyn.s/cm5 
< 30 mL 
< 0.2 cm2 
0-4 ng/mL 
- 32 % 
- 30.7 % 
- 40.5 % 
- 48.9 % 
- 18.4 % 
 
These variables presented in the above mentioned tables are altered with the decrease of the arterial 
pressure. The arterial pressure variation is considered to be related to the sodium nitroprusside administration. 
Although there is always noise in the measurements along with unknown parameters, this relationship was 
proven to be effectively controlled by automatic drug administration systems before. It is our goal to create 
data driven models of these other variables relating them with the variation of the arterial pressure values. 
However, automatic systems today have input methodology constraints as it is not possible to read every 
value mentioned above automatically and in real time. 
 We propose the following working taxonomy for the methods of gathering the patient information: “Basic 
Continuous Monitoring”, “Specific Monitoring” and “Laboratory workup”. 
The laboratory workup values may be entered in the system manually. Regarding these variables, the 
system may present a message to the healthcare professional in order to function as a reminder or an adviser. 
The specific monitoring category encompasses variables that are not expected to be available for every 
patient. Basic continuous monitoring variables should be known in every SNP administration. 
Bellow we provide the variable input methodology tables. It should be kept in mind that this may vary 
greatly from health center to health center. 
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Table 5. Patient gathering information for “Basic continuous monitoring” 
 
Basic continuous monitoring 
Blood pressure 
Heart rate 
Respiratory rate 
Capillary oxygen saturation 
Urine output 
Body temperature 
 
Table 6. Patient gathering information for “Specific monitoring” 
 
Specific monitoring 
Cardiac output 
Stroke volume 
Cardiac index 
Vascular resistances 
Pulmonary capillary pressure  
Central venous pressure 
Mitral regurgitant volume 
Mitral regurgitant orifice area 
 
Table 7. Patient gathering information for “Laboratory Workup” 
 
Laboratory workup 
Arterial blood gas sample: pH, PaO2, PaCO2 
Glucose 
Creatinine 
Urinary sodium 
Lactates 
Creatine kinase-isoenzyme MB 
Thiocyanate 
Methemoglobin 
Atrial natriuretic peptide 
3.3. Preliminary results 
With this information, we applied traditional arterial pressure algorithms to the data of the 72 patients. Due 
to missing data, 14 patients were excluded from the initial study, leaving 58 patient's data available for 
algorithm testing. Taking into consideration the heart rate alone, 23 patients triggered the maximum heart rate 
value rule. Triggering the maximum heart rate rule means that the algorithm increased the heart rate of the 
patient to dangerous levels while trying to control the arterial pressure. The reader is reminded that in order to 
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decrease the mean arterial pressure, an increase in heart rate of approximately 15% occurs for the referred 
drug dosage.  In these situations, the automatic system would need to evaluate the patient's response and the 
risk involved (multiple alternatives are possible).It may not always be possible to maintain optimum values 
for all variables. Variable relevance and current patient state information should be used to create priority 
multipliers. The healthcare professional should always be alerted. The professional can then proceed to 
maintain treatment, cancel it, or to alter the desired set points. The absence of other variable input and the 
knowledge of their dynamics in traditional algorithms is, from what we have seen in the preliminary results, a 
strong limitation. 
In the future, with additional data, automatic systems could make the suggestion of the new set points to 
the doctor in order to maintain optimum variable control. 
Since we are in the process of collecting additional patient data, only the heart rate rules could be tested. 
We are still uncertain of the advantages of this approach when referring to the remaining variables. However, 
the reader must keep in mind that these rules are to be followed, even in manual administration. The question 
is about how many patients would trigger a different set of personalized rules thus enabling a higher control 
quality for automatic SNP administration systems already in production (that do not have intrinsic rules for 
the other variables, just the arterial pressure). 
4. Conclusion 
We developed a multi model methodology for rule creation to be applied to the automatic administration of 
Sodium Nitroprusside. By applying a specific type of model or, if appropriate, the combination of different 
ones to the patient, model dependent rules are placed accordingly for the treatment. These rules can improve 
patient safety as they provide well-determined boundaries in which the controller can operate. 
With this type of approach, medical models that are usually very challenging to acquire, become easier to 
create, via learning algorithms, due to the knowledge of the variables in question. The existence of many 
unknown variables is the main problem of data driven model generation. The variable identification is already 
performed by the healthcare professional – it is a necessary pre-requisite for the manual administration. 
Taking advantage of new models that can be created for each patient, it is possible to evaluate in each case 
the known existing relationship of the arterial pressure decrease with the other variables. This can lead to the 
control of not only the arterial pressure but also the other variables affected by sodium nitroprusside 
administration. 
In the future, with additional data, the system could provide calculations about the optimum compromise 
between rules and variable values to the healthcare professional. This reduces the need for deep control 
knowledge by the end user. 
Knowing which variables are affected decreases the amount of information processed. When noise affects 
one reading, other variable values may be used to determine the certainty of that input. This possibility of 
matching all received variable values to the ones expected by the model, leads to increased error detection 
capabilities and safer measurement. 
However, the biggest contribution of this methodology is the possibility of real world implementation due 
to the wide spectrum of patient characteristics available. 
This system is already under development. Because the majority of the papers published used simulated 
data, or did not disclose the real world patient database, we cannot accurately quantify the benefits of this 
approach. In order to provide better algorithm evaluation we are already recollecting a patient corpus from the 
ICU and do intend to allow access to anonymized patient data in the near future. 
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